Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Market Cap	8.06B -32.1%
Revenue (ttm)	2.73B -9.5%
Net Income	266.27M -43.3%
EPS	1.15 -42.9%
Shares Out	224.98M
PE Ratio	16.33
Forward PE	n/a
Dividend	1.15 (5.96%)
Ex-Dividend Date	Jun 4, 2026

Volume	18,600
Open	18.78
Previous Close	18.79
Day's Range	18.48 - 18.78
52-Week Range	18.49 - 31.28
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 24, 2026

About HKG:6826

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,110
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6826

Financial Performance

In 2025, HKG:6826's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY